composite endpoint

Related by string. * composites . Composites . COMPOSITE . Composite . COMPOSITES : Shanghai composite index . benchmark Shanghai Composite . released composite sketch . volatile Shanghai Composite . Korea Composite / Endpoints . EndPoint . Endpoint . endpoints : Secondary endpoints include . primary efficacy endpoint . secondary efficacy endpoints . video conferencing endpoints * *

Related by context. Frequent words. (Click for all words.) 70 secondary endpoint 67 primary endpoint 66 secondary endpoints 66 bivalirudin 66 Secondary endpoints 66 primary efficacy endpoint 65 myocardial infarction MI 65 treatment emergent adverse 65 efficacy endpoints 64 clinical endpoints 64 unfractionated heparin 64 febrile neutropenia 64 TIMI 63 CYPHER ® Stent 63 LVEF 62 thromboembolism 62 valsartan 62 limiting toxicity 62 evaluable 62 non inferiority 62 Secondary endpoints included 61 enoxaparin 61 events AEs 61 target lesion revascularization 61 laboratory abnormalities 61 bosentan 61 myocardial infarction 61 cardiovascular morbidity 60 confidence interval CI 60 vandetanib 60 mg BID 60 placebo controlled trials 60 chemoradiation 60 mcg kg 60 dose limiting toxicities 60 leukopenia 60 primary endpoints 60 ticagrelor 60 FOLFOX 60 mg dose 60 nonsignificant 60 rosuvastatin 59 tiotropium 59 mitoxantrone 59 hypercalcemia 59 ACTEMRA 59 creatinine clearance 59 myocardial ischemia 59 adalimumab 59 LMWH 59 echocardiographic 59 PEG INTRON 59 HbA1c levels 59 free survival PFS 59 hepatotoxicity 59 RECIST criteria 59 evaluable patients 59 plus ribavirin 58 Secondary endpoints include 58 vinorelbine 58 placebo p = 58 renal dysfunction 58 sustained virologic response 58 CA4P 58 P = .# 58 angina pectoris 58 Adverse events 58 peginterferon alfa 2a 58 tolerated dose MTD 58 statistically significant reduction 58 rivaroxaban 58 elagolix 58 median PFS 58 renal insufficiency 58 monotherapy 58 acute coronary syndromes 58 fluorouracil 58 acute coronary syndrome 58 peginterferon 58 p = #.# [004] 57 stable angina 57 proteinuria 57 phase IIb 57 nasopharyngitis 57 thiazolidinedione 57 liver metastases 57 unstable angina 57 thrombocytopenia 57 abatacept 57 eculizumab 57 discontinuations 57 sunitinib 57 sirolimus 57 azathioprine 57 budesonide 57 metastatic renal cell carcinoma 57 DMARDs 57 lacosamide 57 revascularization 57 antiplatelet therapy 57 etanercept

Back to home page